Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
MIIP encodes a protein that interacts with the oncogene protein insulin-like growth factor binding protein 2 and may function as an inhibitor of cell migration and invasion. Additionally we are shipping MIIP Antibodies (34) and MIIP Kits (3) and many more products for this protein.
Showing 4 out of 4 products:
MIIP expression in esophageal squamous-cell carcinoma tissues was increased significantly in comparison with the paired paracancerous normal epithelia and was associated with cell differentiation. Patients with low MIIP expression had improved overall and disease-free survival. MIIP expression was an independent prognostic factor in ESCC OS and DFS (show FST Proteins).
MIIP attenuates mitotic transition and increases mitotic catastrophe, thereby inhibiting glioma development and progression.
Data show a novel mechanism by which IIp45 inhibits cell motility through inhibition of HDAC6 (show HDAC6 Proteins).
Results suggest MIIP K167E as a functional genetic marker of breast cancer development and prognosis.
identified a gene, invasion inhibitory protein 45 (IIp45), whose protein product bound to IGFBP-2 through the thyroglobulin (show TG Proteins)-RGD region of the C terminus of IGFBP-2
IIp45 gene is inactivated by a tumor-specific alternative splicing that generates an aberrant and unstable IIp45 isoform in infiltrative gliomas.
This gene encodes a protein that interacts with the oncogene protein insulin-like growth factor binding protein 2 and may function as an inhibitor of cell migration and invasion. This protein also interacts with the cell division protein 20 and may be involved in regulating mitotic progression. This protein may function as a tumor suppressor by inhibiting the growth or certain cancers.
, invasion-inhibitory protein 45
, migration and invasion-inhibitory protein
, invasion inhibitory protein 45
, IGFBP-2-Binding Protein, IIp45